| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA | 21 | 2023 | 234 | 9.120 |
Why?
|
| Nucleic Acid Conformation | 17 | 2022 | 142 | 4.150 |
Why?
|
| RNA-Binding Proteins | 8 | 2023 | 145 | 2.190 |
Why?
|
| RNA, Viral | 6 | 2022 | 287 | 1.870 |
Why?
|
| Protein Interaction Mapping | 6 | 2014 | 57 | 1.870 |
Why?
|
| Computational Biology | 8 | 2022 | 275 | 1.760 |
Why?
|
| Sequence Analysis, RNA | 9 | 2022 | 104 | 1.540 |
Why?
|
| Databases, Genetic | 2 | 2021 | 90 | 1.420 |
Why?
|
| Software | 4 | 2021 | 204 | 1.280 |
Why?
|
| Animals | 41 | 2022 | 14307 | 1.100 |
Why?
|
| Genome, Viral | 4 | 2021 | 103 | 1.060 |
Why?
|
| Multiprotein Complexes | 4 | 2014 | 53 | 1.040 |
Why?
|
| High-Throughput Screening Assays | 4 | 2021 | 63 | 1.040 |
Why?
|
| Ribonuclease III | 2 | 2021 | 10 | 0.990 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2021 | 11 | 0.990 |
Why?
|
| Proteins | 5 | 2019 | 352 | 0.920 |
Why?
|
| Microsomes, Liver | 4 | 2010 | 69 | 0.900 |
Why?
|
| Morpholines | 3 | 2010 | 65 | 0.840 |
Why?
|
| RNA Viruses | 1 | 2021 | 22 | 0.840 |
Why?
|
| Mice | 22 | 2022 | 5668 | 0.820 |
Why?
|
| Ficusin | 2 | 2018 | 2 | 0.790 |
Why?
|
| Protein Binding | 10 | 2023 | 913 | 0.790 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 43 | 0.760 |
Why?
|
| Binding Sites | 11 | 2023 | 597 | 0.750 |
Why?
|
| Humans | 44 | 2022 | 34853 | 0.740 |
Why?
|
| Drug Discovery | 1 | 2020 | 77 | 0.730 |
Why?
|
| Models, Statistical | 1 | 2019 | 171 | 0.660 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2010 | 33 | 0.660 |
Why?
|
| Models, Molecular | 11 | 2022 | 751 | 0.650 |
Why?
|
| Viral Envelope Proteins | 1 | 2018 | 77 | 0.650 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 25 | 0.640 |
Why?
|
| Gene Expression Regulation | 8 | 2023 | 968 | 0.570 |
Why?
|
| Proteomics | 4 | 2013 | 302 | 0.570 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 40 | 0.550 |
Why?
|
| Databases, Protein | 2 | 2012 | 47 | 0.540 |
Why?
|
| Algorithms | 5 | 2017 | 435 | 0.520 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 30 | 0.510 |
Why?
|
| Chromatin | 4 | 2022 | 164 | 0.510 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 68 | 0.500 |
Why?
|
| Indoles | 2 | 2006 | 154 | 0.490 |
Why?
|
| RNA, Messenger | 7 | 2021 | 1152 | 0.480 |
Why?
|
| RNA Probes | 3 | 2022 | 10 | 0.460 |
Why?
|
| Protein Biosynthesis | 5 | 2021 | 123 | 0.440 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 303 | 0.430 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 341 | 0.420 |
Why?
|
| Internet | 5 | 2021 | 204 | 0.420 |
Why?
|
| Signal Transduction | 7 | 2022 | 1802 | 0.420 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 40 | 0.410 |
Why?
|
| Tamoxifen | 4 | 2016 | 61 | 0.400 |
Why?
|
| Membrane Proteins | 1 | 2014 | 486 | 0.390 |
Why?
|
| Breast Neoplasms | 8 | 2020 | 1426 | 0.390 |
Why?
|
| Indomethacin | 1 | 2010 | 24 | 0.380 |
Why?
|
| Molecular Structure | 5 | 2021 | 467 | 0.370 |
Why?
|
| Protein Conformation | 5 | 2014 | 350 | 0.350 |
Why?
|
| Prodrugs | 3 | 2015 | 22 | 0.350 |
Why?
|
| Ribosomal Proteins | 2 | 2019 | 19 | 0.340 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 550 | 0.340 |
Why?
|
| Cell Line, Tumor | 12 | 2022 | 2128 | 0.320 |
Why?
|
| Cell Line | 3 | 2021 | 1289 | 0.320 |
Why?
|
| Receptors, Cannabinoid | 2 | 2004 | 26 | 0.320 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 63 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2016 | 209 | 0.300 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 756 | 0.280 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 115 | 0.280 |
Why?
|
| MicroRNAs | 3 | 2022 | 386 | 0.280 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2015 | 406 | 0.280 |
Why?
|
| User-Computer Interface | 2 | 2018 | 62 | 0.270 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 430 | 0.260 |
Why?
|
| Piperidines | 1 | 2004 | 76 | 0.250 |
Why?
|
| Pyrazoles | 1 | 2004 | 80 | 0.250 |
Why?
|
| Mass Spectrometry | 3 | 2015 | 255 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1530 | 0.240 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2015 | 31 | 0.240 |
Why?
|
| Substrate Specificity | 2 | 2021 | 186 | 0.230 |
Why?
|
| Base Sequence | 4 | 2018 | 932 | 0.230 |
Why?
|
| Antiviral Agents | 2 | 2021 | 148 | 0.230 |
Why?
|
| G-Quadruplexes | 1 | 2022 | 5 | 0.230 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 198 | 0.230 |
Why?
|
| Smad7 Protein | 1 | 2022 | 4 | 0.230 |
Why?
|
| Transposases | 1 | 2022 | 8 | 0.230 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 2 | 2020 | 4 | 0.220 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 1 | 0.220 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2020 | 109 | 0.220 |
Why?
|
| Astrocytoma | 1 | 2022 | 13 | 0.220 |
Why?
|
| Naphthalenes | 1 | 2002 | 37 | 0.220 |
Why?
|
| Nucleotides | 1 | 2022 | 33 | 0.220 |
Why?
|
| Oogenesis | 1 | 2022 | 23 | 0.220 |
Why?
|
| Bayes Theorem | 2 | 2012 | 91 | 0.220 |
Why?
|
| Receptors, Drug | 1 | 2002 | 56 | 0.220 |
Why?
|
| Nuclear Factor 90 Proteins | 1 | 2022 | 1 | 0.220 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2022 | 2 | 0.210 |
Why?
|
| Zebrafish | 2 | 2020 | 118 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2022 | 347 | 0.210 |
Why?
|
| Interferon Type I | 1 | 2022 | 17 | 0.210 |
Why?
|
| Cannabinoids | 1 | 2002 | 54 | 0.210 |
Why?
|
| RNA Splicing | 2 | 2021 | 36 | 0.210 |
Why?
|
| Drug Design | 2 | 2020 | 154 | 0.210 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 59 | 0.210 |
Why?
|
| Cilia | 1 | 2021 | 23 | 0.210 |
Why?
|
| Virus Replication | 2 | 2021 | 261 | 0.210 |
Why?
|
| Liver | 1 | 2004 | 447 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 52 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2021 | 40 | 0.200 |
Why?
|
| RNA, Fungal | 1 | 2021 | 7 | 0.200 |
Why?
|
| RNA Editing | 1 | 2021 | 36 | 0.200 |
Why?
|
| Reverse Transcription | 2 | 2018 | 16 | 0.200 |
Why?
|
| RNA, Plant | 1 | 2021 | 24 | 0.200 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 29 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2021 | 122 | 0.200 |
Why?
|
| Disease | 1 | 2020 | 18 | 0.200 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 74 | 0.200 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 168 | 0.190 |
Why?
|
| RNA, Double-Stranded | 2 | 2021 | 23 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 161 | 0.190 |
Why?
|
| Ribosomes | 2 | 2017 | 27 | 0.190 |
Why?
|
| Hepatitis E virus | 1 | 2020 | 4 | 0.190 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2020 | 3 | 0.190 |
Why?
|
| DNA, Complementary | 2 | 2018 | 175 | 0.190 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2020 | 26 | 0.190 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 41 | 0.190 |
Why?
|
| Mutation | 3 | 2020 | 1023 | 0.190 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 136 | 0.190 |
Why?
|
| Estrogens | 2 | 2013 | 190 | 0.190 |
Why?
|
| Viral Proteins | 1 | 2021 | 172 | 0.190 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 42 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 1 | 2020 | 57 | 0.180 |
Why?
|
| Doxorubicin | 1 | 2020 | 80 | 0.180 |
Why?
|
| RNA, Transfer | 1 | 2019 | 26 | 0.180 |
Why?
|
| Leucine | 1 | 2019 | 28 | 0.180 |
Why?
|
| Normal Distribution | 1 | 2019 | 15 | 0.180 |
Why?
|
| Genomics | 1 | 2021 | 201 | 0.180 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2018 | 79 | 0.180 |
Why?
|
| Aldehydes | 1 | 2020 | 65 | 0.180 |
Why?
|
| Monocytes | 1 | 2022 | 258 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2022 | 653 | 0.180 |
Why?
|
| Rats | 5 | 2010 | 3261 | 0.180 |
Why?
|
| Leukemia | 1 | 2019 | 54 | 0.170 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 122 | 0.170 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 70 | 0.170 |
Why?
|
| Cluster Analysis | 1 | 2019 | 188 | 0.170 |
Why?
|
| Vero Cells | 1 | 2018 | 90 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 182 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 162 | 0.170 |
Why?
|
| Gene Expression Profiling | 3 | 2022 | 600 | 0.170 |
Why?
|
| Stem Cells | 1 | 2019 | 132 | 0.170 |
Why?
|
| RNA, Transfer, Leu | 1 | 2017 | 1 | 0.160 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1149 | 0.160 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 48 | 0.160 |
Why?
|
| Hela Cells | 4 | 2022 | 344 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2015 | 173 | 0.160 |
Why?
|
| Structure-Activity Relationship | 5 | 2014 | 376 | 0.150 |
Why?
|
| Data Mining | 1 | 2017 | 21 | 0.150 |
Why?
|
| Sterols | 1 | 2016 | 22 | 0.150 |
Why?
|
| Female | 13 | 2022 | 19873 | 0.150 |
Why?
|
| Boronic Acids | 1 | 2016 | 19 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 901 | 0.150 |
Why?
|
| Pyridines | 2 | 2014 | 113 | 0.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 28 | 0.140 |
Why?
|
| Genome, Insect | 1 | 2016 | 7 | 0.140 |
Why?
|
| Mitochondria | 1 | 2020 | 454 | 0.140 |
Why?
|
| ROC Curve | 2 | 2013 | 138 | 0.140 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2015 | 17 | 0.140 |
Why?
|
| Aminophenols | 1 | 2015 | 2 | 0.140 |
Why?
|
| Cell Movement | 3 | 2014 | 545 | 0.130 |
Why?
|
| Monophenol Monooxygenase | 1 | 2015 | 11 | 0.130 |
Why?
|
| Agaricales | 1 | 2015 | 6 | 0.130 |
Why?
|
| Oxazines | 1 | 2015 | 23 | 0.130 |
Why?
|
| Cell Nucleus | 3 | 2022 | 351 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 298 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 638 | 0.130 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.130 |
Why?
|
| Phylogeny | 2 | 2019 | 612 | 0.120 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 16 | 0.120 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 168 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2017 | 242 | 0.120 |
Why?
|
| Thiazoles | 1 | 2014 | 71 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 1300 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2014 | 392 | 0.120 |
Why?
|
| Nitriles | 1 | 2013 | 66 | 0.110 |
Why?
|
| Mesoderm | 2 | 2013 | 70 | 0.110 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 5 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 6 | 0.110 |
Why?
|
| Triazoles | 1 | 2013 | 85 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2012 | 49 | 0.110 |
Why?
|
| Cadherins | 1 | 2012 | 82 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2012 | 91 | 0.110 |
Why?
|
| Bacteroides | 1 | 2012 | 8 | 0.110 |
Why?
|
| Mammals | 2 | 2022 | 96 | 0.110 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 38 | 0.100 |
Why?
|
| Ligands | 2 | 2022 | 317 | 0.100 |
Why?
|
| Proteome | 1 | 2012 | 132 | 0.100 |
Why?
|
| RNA Stability | 2 | 2021 | 24 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 193 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2012 | 97 | 0.100 |
Why?
|
| RNA Precursors | 2 | 2021 | 25 | 0.100 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 26 | 0.100 |
Why?
|
| Structural Homology, Protein | 1 | 2010 | 13 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 528 | 0.090 |
Why?
|
| Systems Biology | 1 | 2010 | 20 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 94 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2012 | 520 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2010 | 106 | 0.090 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 158 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2010 | 257 | 0.090 |
Why?
|
| Isoflavones | 1 | 2010 | 125 | 0.090 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2008 | 4 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2008 | 8 | 0.090 |
Why?
|
| Epithelium | 1 | 2008 | 74 | 0.080 |
Why?
|
| Benzamidines | 1 | 2007 | 4 | 0.080 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2007 | 6 | 0.080 |
Why?
|
| Trypanosomiasis, African | 1 | 2007 | 23 | 0.080 |
Why?
|
| RNA Splice Sites | 2 | 2020 | 10 | 0.080 |
Why?
|
| Open Reading Frames | 2 | 2020 | 73 | 0.080 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 57 | 0.080 |
Why?
|
| Trypanocidal Agents | 1 | 2007 | 39 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 67 | 0.080 |
Why?
|
| Base Pairing | 2 | 2017 | 42 | 0.080 |
Why?
|
| Cell Survival | 3 | 2017 | 818 | 0.070 |
Why?
|
| Piperazines | 1 | 2007 | 109 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 325 | 0.070 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2007 | 80 | 0.070 |
Why?
|
| Biological Availability | 2 | 2016 | 84 | 0.070 |
Why?
|
| DNA | 2 | 2019 | 549 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 2 | 2018 | 61 | 0.070 |
Why?
|
| Brain | 1 | 2012 | 1268 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 555 | 0.060 |
Why?
|
| Chick Embryo | 2 | 2014 | 71 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 650 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 281 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 129 | 0.060 |
Why?
|
| Estrogen Receptor alpha | 2 | 2016 | 105 | 0.060 |
Why?
|
| Activins | 1 | 2022 | 7 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 247 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2022 | 22 | 0.060 |
Why?
|
| Benzoxazines | 1 | 2002 | 46 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2016 | 420 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2015 | 323 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2016 | 212 | 0.050 |
Why?
|
| Oocytes | 1 | 2022 | 143 | 0.050 |
Why?
|
| RNA, Helminth | 1 | 2021 | 4 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2021 | 17 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2021 | 20 | 0.050 |
Why?
|
| Containment of Biohazards | 1 | 2021 | 1 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 183 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 203 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 287 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2021 | 423 | 0.050 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2020 | 4 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2020 | 13 | 0.050 |
Why?
|
| Butanones | 1 | 2020 | 5 | 0.050 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 24 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2020 | 9 | 0.050 |
Why?
|
| Replication Protein A | 1 | 2020 | 8 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 80 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2020 | 87 | 0.050 |
Why?
|
| Liposomes | 1 | 2020 | 107 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 45 | 0.050 |
Why?
|
| Guanine | 1 | 2020 | 45 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 61 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 562 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 286 | 0.040 |
Why?
|
| Male | 4 | 2022 | 18870 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 522 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 834 | 0.040 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2018 | 1 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 649 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2018 | 37 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2018 | 52 | 0.040 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2017 | 8 | 0.040 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2017 | 4 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2017 | 38 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 34 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 577 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 781 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 639 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2017 | 58 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 485 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2016 | 7 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2016 | 162 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2020 | 294 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 147 | 0.030 |
Why?
|
| Acylation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 47 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 29 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 81 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 79 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 131 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 195 | 0.030 |
Why?
|
| Adenosine | 1 | 2015 | 54 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 87 | 0.030 |
Why?
|
| Genome | 1 | 2015 | 117 | 0.030 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 89 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 143 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 64 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 46 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 107 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 56 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 162 | 0.030 |
Why?
|
| Oxygen | 1 | 2015 | 193 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 70 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 407 | 0.030 |
Why?
|
| Point Mutation | 1 | 2014 | 88 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 80 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 85 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 650 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 162 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 35 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 32 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 30 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 30 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2013 | 52 | 0.030 |
Why?
|
| Genome, Human | 1 | 2014 | 112 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 211 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2013 | 207 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 66 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 117 | 0.030 |
Why?
|
| New Orleans | 1 | 2012 | 11 | 0.030 |
Why?
|
| Ethinyl Estradiol | 1 | 2012 | 9 | 0.030 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 10 | 0.030 |
Why?
|
| Histones | 1 | 2013 | 177 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2014 | 287 | 0.030 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2012 | 2 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2012 | 17 | 0.030 |
Why?
|
| Geologic Sediments | 1 | 2012 | 41 | 0.030 |
Why?
|
| Fresh Water | 1 | 2012 | 47 | 0.030 |
Why?
|
| Seawater | 1 | 2012 | 46 | 0.030 |
Why?
|
| Mississippi | 1 | 2012 | 107 | 0.030 |
Why?
|
| Pesticides | 1 | 2012 | 44 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 42 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 72 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2012 | 40 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 78 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 220 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2013 | 226 | 0.030 |
Why?
|
| Phenols | 1 | 2012 | 76 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2013 | 328 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1681 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 145 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 383 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 52 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1317 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 78 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2008 | 21 | 0.020 |
Why?
|
| Estradiol | 1 | 2010 | 244 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 185 | 0.020 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2007 | 14 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 140 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2007 | 93 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 605 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 391 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2875 | 0.020 |
Why?
|